内地西藏籍大学生非酒精性脂肪性肝病现况调查及危险因素分析
A Cross-Sectional Investigation for Prevalence and Risk Factors of Non-Alcoholic Fatty Liver Disease in Tibetan College Students in Mainland
DOI: 10.12677/ACM.2024.142402, PDF,    科研立项经费支持
作者: 周 娟*:西藏民族大学附属医院内科,陕西 咸阳;毋瑞朋*:西藏民族大学医学院,陕西 咸阳;王宇鹤:西藏民族大学附属医院检验科,陕西 咸阳;李 莉:西藏民族大学附属医院超声科,陕西 咸阳;杨 伟:西藏民族大学附属医院急诊科,陕西 咸阳;牛春燕:南京溧水区人民医院消化内科,江苏 南京;董鸿智#:西藏民族大学附属医院中医康复科,陕西 咸阳
关键词: 内地西藏籍大学生非酒精性脂肪性肝病现况调查危险因素The Tibetan College Students in Mainland Non-Alcoholic Fatty Liver Disease Cross-Sectional Investigation Risk Factors
摘要: 目的:对内地西藏籍大学生的非酒精性脂肪性肝病(non-alcoholic fatty liver disease, NAFLD)现况进行调查并分析其危险因素,为高海拔地区青年人群NAFLD的进一步研究提供科学依据。方法:采用方便抽样,于2022年7月对参与调研的400名来内地求学的、西藏籍学生进行问卷调查、体格检查、腹部超声检查及血清学检查,运用SPSS 18.0软件对符合纳入标准的386名学生的相关数据进行分析总结。结果:1) 386名学生中,NAFLD 59例(15.3%),其中轻度脂肪肝51例(13.2%)、中度脂肪肝5例(1.2%),重度脂肪肝3例(0.8%),女性患病率(16.9%)高于男性(13.0%)。2) 在59名NAFLD学生中,体重正常7例(11.9%),有肥胖风险30例(50.8%),肥胖22例(37.3%)。3) NAFLD学生比非NAFLD学生的ALT [(20 ± 22.7) U/L vs (13.9 ± 22.7) U/L)]、腹围[(86.81 ± 9.29) cm vs (73.68 ± 6.79) cm]、腰臀比[(0.88 ± 0.05) vs (0.84 ± 0.06)]、BMI [(26.60 ± 3.78) kg/m2 vs (20.39 ± 2.56) kg/m2]、VAI [(1.98 ± 1.24) cm2/10cm vs (1.42 ± 0.75) cm2/10cm]均高于非NAFLD (P均<0.01)。4) 在对生活习惯分析时发现,男性中经常运动的人数(72%,占全部锻炼人数的52.7%)多于女性(46.2%,占全部锻炼人数的47.3%) (χ2 = 25.5, P = 0.000)、男性的每周锻炼的频次(3.03 ± 1.41)也多于(t = 2.9, P < 0.01)女性(2.48 ± 1.42);女性每天静坐的时间(4.31 ± 2.13)长于(t = −2.7, P < 0.01)男性(3.73 ± 1.96)。饮食方面:女性每周含糖饮料的摄入杯数(3.98 ± 2.67)多于(t = 6.46, P = 0.000)男性(2.26 ± 1.68);男性总体进食蔬菜的量小于女性(χ2 = 9.33, P = 0.025)。结论:1) 内地西藏籍大学生NAFLD的患病率处于国内较低、高校中较高水平;2) BMI、腹围、腰臀比和VAI的增大、ALT的升高可作为NAFLD的筛查指标;3) 久坐少动、运动量少、含糖饮料摄入多是本此次研究中女性患病率高于男性的主要危险因素。4) 非肥胖型NAFLD患病率接近肥胖型NAFLD的患病率,需引起重视。
Abstract: Objective: To investigate prevalence and risk factors of non-alcoholic fatty liver disease (NAFLD) in inland Tibetan college students, to provide a scientific basis for further research of NAFLD in the youth population at high altitude. Methods: Convenience sampling was used to choose students. Questionnaire survey, physical examination, abdominal ultrasound examination and serological examination were conducted to 400 Tibetan students who studying in mainland in 2022 July. 386 complyed with the inclusion criteria individuals’ data were summarized and analyzed by SPSS 18.0 Software. Results: 1) 59 students (13.2%) were diagnosed as NAFLD in total 386 subjects, including, 51 mild NAFLD (13.2%), 5 moderate NAFLD (1.2%) and 3 severe NAFLD (0.8%). The prevalence of female higher (16.9%) than that of male (13.0%). 2) Among the 59 NAFLD students, 7 (11.9%) were normal weight, 30 (50.8%) were overload and 22 (37.3%) were obese. 3) The ALT [(20 ± 22.7) U/L vs (13.9 ± 22.7) U/L)], circumference of abdomen [(86.81 ± 9.29) cm vs (73.68 ± 6.79) cm], waist-to-hipratio [(0.88 ± 0.05) vs (0.84 ± 0.06)], BMI [(26.60 ± 3.78) kg/m2 vs (20.39 ± 2.56) kg/m2], VAI [(1.98 ± 1.24) cm2/10cm vs(1.42 ± 0.75) cm2/10cm] of NAFLD students were higher than non-NAFLD (P < 0.01). 4) In the analysis of lifestyle habits, it was found that men exercised more (72%, 52.7% among the total number of exercise people) than women (46.2%, 47.3% among the total number of exercise people) (χ2 = 25.5, P = 0.000), the frequency of weekly exercise of men (3.03 ± 1.41) was more than (t = 2.9, P < 0.01) that of women (2.48 ± 1.42), the siting time per day of women (4.31 ± 2.13) is longer than (3.73 ± 1.96) that of men (t = −2.7, P < 0.01). We also found that, women consumed sugary drinks per day (3.98 ± 2.67) than (t = 6.46, P = 0.000) men (2.26 ± 1.68), and men consumed less vegetables than women (χ2 = 9.33, P = 0.025). Conclusions: 1) The preva-lence of NAFLD among Tibetan college students in the mainland is relatively lower than national average but higher than other universities in the other regions. 2) Higher ALT, BMI, WC, waist-to- hip ratio and VAI can be used as screening indicators for NAFLD. 3) Sedentary time, lack of aerobic exercise, insufficient intake of vegetables, and regular weekly intake of sugary drinks are the mate-rial cause of the higher prevalence in women than in men. 4) The incidence of non-obese NAFLD is close to that of obese NAFLD, which should be paid attention to.
文章引用:周娟, 毋瑞朋, 王宇鹤, 李莉, 杨伟, 牛春燕, 董鸿智. 内地西藏籍大学生非酒精性脂肪性肝病现况调查及危险因素分析[J]. 临床医学进展, 2024, 14(2): 2843-2851. https://doi.org/10.12677/ACM.2024.142402

参考文献

[1] Powell, E.E., Wong, V.W. and Rinella, M. (2021) Non-Alcoholic Fatty Liver Disease. The Lancet, 397, 2212-2224. [Google Scholar] [CrossRef
[2] Younossi, Z.M., Noureddin, M., Bernstein, D., et al. (2021) Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients with Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations. American Journal of Gastroenterology, 116, 254-262. [Google Scholar] [CrossRef] [PubMed]
[3] Torres-Peña, J.D., Arenas-De Larriva, A.P., Alcala-Diaz, J.F., et al. (2023) Different Dietary Approaches, Non-Alco- holic Fatty Liver Disease and Cardiovascular Disease: A Literature Review. Nutrients, 15, Article No. 1483. [Google Scholar] [CrossRef] [PubMed]
[4] Zhou, J., Zhou, F., Wang, W., et al. (2020) Epidemiological Features of NAFLD from 1999 to 2018 in China. Hepatology, 71, 1851-1864. [Google Scholar] [CrossRef] [PubMed]
[5] Eslam, M., Sanyal, A.J. and George, J. (2020) MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associat-ed Fatty Liver Disease. Gastroenterology, 158, 1999-2014.e1. [Google Scholar] [CrossRef] [PubMed]
[6] McGlinchey, A.J., Govaere, O., Geng, D., et al. (2022) Metabol-ic Signatures across the Full Spectrum of Non-Alco- holic Fatty Liver Disease. JHEP Reports, 4, Article ID: 100477. [Google Scholar] [CrossRef] [PubMed]
[7] Gofton, C., Upendran, Y., Zheng, M.H., et al. (2023) MAFLD: How Is It Different from NAFLD? Clinical and Molecular Hepatology, 29, S17-S31. [Google Scholar] [CrossRef] [PubMed]
[8] Harrison, S.A., Ratziu, V., Boursier, J., et al. (2020) A Blood-Based Biomarker Panel (NIS4) for Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis and Liver Fibrosis: A Prospective Derivation and Global Validation Study. The Lancet Gastroenterology and Hepatology, 5, 970-985. [Google Scholar] [CrossRef
[9] Stefan, N. and Cusi, K. (2022) A Global View of the Inter-play between Non-Alcoholic Fatty Liver Disease and Diabetes. The Lancet Diabetes & Endocrinology, 10, 284-296. [Google Scholar] [CrossRef
[10] Ezpeleta, M., Gabel, K., Cienfuegos, S., et al. (2023) Alter-nate-Day Fasting Combined with Exercise: Effect on Sleep in Adults with Obesity and NAFLD. Nutrients, 15, Article No. 1398. [Google Scholar] [CrossRef] [PubMed]
[11] En Li Cho, E., Ang, C.Z., Quek, J., et al. (2023) Global Prev-alence of Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: An Updated Systematic Review and Me-ta-Analysis. Gut, 72, 2138-2148. [Google Scholar] [CrossRef] [PubMed]
[12] Allen, A.M., Lazarus, J.V. and Younossi, Z.M. (2023) Healthcare and Socioeconomic Costs of NAFLD: A Global Framework to Navigate the Uncertainties. Journal of Hepatology, 79, 209-217. [Google Scholar] [CrossRef] [PubMed]
[13] 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病防治指南(2018年更新版) [J]. 临床肝胆病杂志, 2018, 34(5): 947-957. [Google Scholar] [CrossRef
[14] Weisell, R.C. (2002) Body Mass Index as an Indicator of Obesity. Asia Pacific Journal of Clinical Nutrition, 11, S681- S684. [Google Scholar] [CrossRef
[15] Peng, H., Pan, L., Ran, S., et al. (2023) Prediction of MAFLD and NAFLD Using Different Screening Indexes: A Cross-Sectional Study in U.S. Adults. Frontiers in Endocrinology (Lausanne), 14, Article ID: 1083032. [Google Scholar] [CrossRef] [PubMed]
[16] He, Y., Su, Y., Duan, C., et al. (2023) Emerging Role of Aging in the Progression of NAFLD to HCC. Ageing Research Reviews, 84, Article ID: 101833. [Google Scholar] [CrossRef] [PubMed]
[17] Mao, T., Sun, Y., Xu, X., et al. (2023) Overview and Prospect of NAFLD: Significant Roles of Nutrients and Dietary Patterns in Its Progression or Prevention. Hepatology Communica-tions, 7, e0234. [Google Scholar] [CrossRef
[18] 陈红, 赵莎莎, 杨婉君. 河南省焦作市高校新生膳食及生活行为方式与非酒精性脂肪肝的关系[J]. 实用预防医学, 2022, 29(9): 1115-1118. [Google Scholar] [CrossRef
[19] 杜秋菊, 束龙, 叶翔, 等. 杭州市6所高校大学新生膳食模式与非酒精性脂肪肝的关系[J]. 中国学校卫生, 2019, 40(3): 434-436+440. [Google Scholar] [CrossRef
[20] Liu, X., Peng, Y., Chen, S., et al. (2018) An Obser-vational Study on the Association between Major Dietary Patterns and Non-Alcoholic Fatty Liver Disease in Chinese Adolescents. Medicine (Baltimore), 97, e0576. [Google Scholar] [CrossRef
[21] 祁生贵, 更登, 李莉, 等. 非酒精性脂肪性肝病在不同海拔及不同民族人群中的患病率[J]. 环境卫生学杂志, 2022, 12(7): 533-536. [Google Scholar] [CrossRef
[22] 蔡浩. 慢性低氧对小鼠非酒精性脂肪肝炎的调控机制研究[D]: [博士学位论文]. 青海: 青海大学, 2022.
[23] Dolce, A. and Della Torre, S. (2023) Sex, Nutrition, and NAFLD: Relevance of Environmental Pollution. Nutrients, 15, Article No. 2335. [Google Scholar] [CrossRef] [PubMed]
[24] Pan, Y. and Zhang, X. (2022) Diet and Gut Microbiome in Fatty Liver and Its Associated Liver Cancer. Journal of Gastroenterology and Hepatology, 37, 7-14. [Google Scholar] [CrossRef] [PubMed]
[25] Yahoo, N., Dudek, M., Knolle, P., et al. (2023) Role of Immune Responses in the Development of NAFLD-Associated Liver Cancer and Prospects for Therapeutic Modulation. Journal of Hepa-tology, 79, 538-551. [Google Scholar] [CrossRef] [PubMed]
[26] Glass, O., Filozof, C., Noureddin, M., et al. (2020) Standardisation of Diet and Exercise in Clinical Trials of NAFLD- NASH: Recommendations from the Liver Forum. Journal of Hepa-tology, 73, 680-693. [Google Scholar] [CrossRef] [PubMed]
[27] Semmler, G., Datz, C., Reiberger, T., et al. (2021) Diet and Exer-cise in NAFLD/NASH: Beyond the Obvious. Liver International, 41, 2249-2268. [Google Scholar] [CrossRef] [PubMed]
[28] Jensen, T., Abdelmalek, M.F., Sullivan, S., et al. (2018) Fructose and Sugar: A Major Mediator of Non-Alcoholic Fatty Liver Disease. Journal of Hepatology, 68, 1063-1075. [Google Scholar] [CrossRef] [PubMed]
[29] Coronati, M., Baratta, F., Pastori, D., et al. (2022) Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review. Nutrients, 14, Article No. 1127. [Google Scholar] [CrossRef] [PubMed]
[30] Softic, S., Stanhope, K.L., Boucher, J., et al. (2020) Fructose and Hepatic Insulin Resistance. Critical Reviews in Clinical Laboratory Sciences, 57, 308-322. [Google Scholar] [CrossRef] [PubMed]
[31] Xu, R., Pan, J., Zhou, W., et al. (2022) Recent Advances in Lean NAFLD. Biomedicine & Pharmacotherapy, 153, Article ID: 113331. [Google Scholar] [CrossRef] [PubMed]
[32] Nabi, O., Lapidus, N., Boursier, J., et al. (2023) Lean Individu-als with NAFLD Have More Severe Liver Disease and Poorer Clinical Outcomes (NASH-CO Study). Hepatology, 78, 272-283. [Google Scholar] [CrossRef
[33] Xu, C., Ma, Z., Wang, Y., et al. (2018) Visceral Adiposity Index as a Predictor of NAFLD: A Prospective Study with 4-Year Follow-Up. Liver International, 38, 2294-2300. [Google Scholar] [CrossRef] [PubMed]
[34] Tang, M., Wei, X.H., Cao, H., et al. (2022) Association between Chinese Visceral Adiposity Index and Metabolic- Associated Fatty Liver Disease in Chinese Adults with Type 2 Diabetes Melli-tus. Frontiers in Endocrinology (Lausanne), 13, Article ID: 935980. [Google Scholar] [CrossRef] [PubMed]
[35] Ismaiel, A., Jaaouani, A., Leucuta, D.C., et al. (2021) The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis. Bio-medicines, 9, Article No. 1890. [Google Scholar] [CrossRef] [PubMed]